Fingerprint
Dive into the research topics of 'Phase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528/NRG-GY002)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528/NRG-GY002)
Alessandro D. Santin, Wei Deng, Michael Frumovitz, Natalia Buza, Stefania Bellone, Warner Huh, Samir Khleif, Heather A. Lankes, Elena S. Ratner, Roisin E. O'Cearbhaill, Amir A. Jazaeri, Michael Birrer
Research output: Contribution to journal › Article › peer-review
98
Scopus
citations